Genmab | GEN - Interest Expense On Debt


Genmab reported DKK10M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Agios Pharmaceuticals USD 1.39B 85.53M Sep/2025
Amarin USD 3K 5K Dec/2024
Amgen USD 653M 32M Dec/2025
argenx SE USD 828K 165K Dec/2025
AstraZeneca USD 484M 181M Dec/2025
Bayer EUR 675M 87M Dec/2025
BioMarin Pharmaceutical USD 2.78M 199K Dec/2025
Demant DKK 398M 37M Dec/2025
Exelixis USD 23.4M 3.9M Sep/2023
Fresenius Medical Care EUR 85M 8.1M Dec/2025
Galapagos EUR 1.72M 940K Sep/2025
Genmab DKK 10M 27M Dec/2025
GlaxoSmithKline GBP 188M 21M Dec/2025
GN Store Nord DKK 296M 42M Dec/2025
GRIFOLS EUR 141.43M 61.28M Jun/2025
Hikma Pharmaceutical USD 67M 47M Dec/2025
Insmed USD 20.6M 217K Dec/2025
Lonza CHF 84M 14M Jun/2025
Merck EUR 121M 5M Dec/2025
Novartis USD 304M 23M Dec/2025
Regeneron Pharmaceuticals USD 12.2M 7.1M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR -25M 252M Dec/2025
UCB EUR 49M 29M Dec/2025